Finance

Beta
Lists
PRCT:NASDAQ
Procept Biorobotics Corp
$22.56
+4.98%
(+1.07) 1D
Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRCT...
Open
$21.55
High
$22.80
Low
$21.46
Mkt. cap
1.28B
Avg. vol.
1.61M
Volume
0.00
52-wk high
$62.17
52-wk low
$19.35
EPS
-$1.83
Beta
0.85
Shares outstanding
56.92M
No. of employees
888
Open
$21.55
High
$22.80
Low
$21.46
Mkt. cap
1.28B
Avg. vol.
1.61M
Volume
0.00
52-wk high
$62.17
52-wk low
$19.35
EPS
-$1.83
Beta
0.85
Shares outstanding
56.92M
No. of employees
888
News stories
From sources across the web
Stock Traders Daily
Stock Traders Daily
·
19 hours ago
Trading Systems Reacting to (PRCT) Volatility
About Procept Biorobotics Corp
CEO-
Employees888
Founded2007
HeadquartersSan Jose, California, United States
SectorMedical device
Websiteprocept-biorobotics.com
Analyst ratings
Based on 9 analysts giving stock ratings to PRCT in the past 3 months
Buy
Buy
5
Hold
3
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for PRCT in the last 3 months.
Highest
Current $22.56
$35.00 (+55.14%)
Average
$29.33 (+30.01%)
Lowest
$20.00 (-11.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vijay Kumar
Evercore ISI
Buy
Initiated
$30.00
+33%
06/24/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
06/23/2026
Mike Kratky
Leerink Partners
Hold
Downgraded
$29.00
+28.5%
06/12/2026
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
06/02/2026
Josh Jennings
TD Cowen
Buy
Reiterated
$34.00
+50.7%
06/01/2026
Stephanie Piazzola
Bank of America Securities
Sell
Maintained
$20.00
-11.3%
05/13/2026
Richard Newitter
Truist Financial
Buy
Maintained
-
-
04/30/2026
Matthew O'Brien
Piper Sandler
Buy
Maintained
$35.00
+55.1%
04/30/2026
David Rescott
Robert W. Baird
Hold
Maintained
$28.00
+24.1%
04/30/2026
Nathan Treybeck
Wells Fargo
Buy
Maintained
$34.00
+50.7%
03/20/2026
Patrick Wood
Morgan Stanley
Buy
Reiterated
$51.00
+126.1%
03/11/2026
Danielle Antalffy
UBS
Buy
Maintained
$30.00
+33%
03/02/2026
Suraj Kalia
Oppenheimer
Hold
Downgraded
$60.00
+166%
02/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
79.18M
83.33M
76.38M
83.13M
Cost of goods sold
27.44M
29.32M
30.07M
29.18M
Cost of revenue
27.44M
29.32M
30.07M
29.18M
Research and development expenses
17.63M
18.19M
19.06M
21.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.30M
59.01M
58.30M
65.09M
Operating expense
73.94M
77.20M
77.35M
86.55M
Total operating expenses
101.37M
106.52M
107.42M
115.74M
Operating income
-22.19M
-23.19M
-31.04M
-32.61M
Other non operating income
-
-
-156.00K
-
EBT including unusual items
-19.58M
-21.41M
-29.66M
-31.68M
EBT excluding unusual items
-19.58M
-21.41M
-29.66M
-31.68M
Income tax expense
-
-
190.00K
-43.00K
Effective tax rate
-
-
-0.64%
0.14%
Other operating expenses
-
-
-
-
Net income
-19.58M
-21.41M
-29.84M
-31.64M
Net profit margin
-24.73%
-25.70%
-39.07%
-38.06%
Earnings per share
-0.35
-0.38
-0.53
-0.56
Interest and investment income
3.51M
2.70M
2.44M
1.74M
Interest expense
-895.00K
-919.00K
-894.00K
-818.00K
Net interest expenses
2.61M
1.78M
1.54M
925.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.60M
-21.57M
-29.33M
-30.87M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of PRCT
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer